Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma
Clinical trial NCT03960177 · COMPLETED
Trial details
- NCT number
- NCT03960177
- Sponsor
- OHSU Knight Cancer Institute
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-27
- Primary completion
- 2025-12-31
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.